Background: The aim of this study was to perform a standardized and systematic evaluation of the available evidence on multi-item shoulder-specific patient-reported outcome measures that are applicable to a wide spectrum of disorders. Materials and methods: A systematic review was conducted in PubMed to identify articles with information regarding the development process, metric properties, and administration issues of shoulder-specific patient-reported outcome measures. Two experts independently reviewed all the articles identified for one instrument and applied the EMPRO (Evaluating Measures of Patient Reported Outcomes) tool, which was designed to assess the quality of attributes in a standardized way. An overall EMPRO score and 6 attribute-specific scores were calculated (range, 0-100) to describe the quality of instrument performance. The shoulder is one of the most complex joints of the human body. Shoulder-related disorders account for substantial medical, economic, and social costs 21, 43, 46 and comprise a wide spectrum of problems. Shoulder disorders are mostly accompanied by pain and restricted movement of the arm or shoulder that lead to difficulties in performing certain activities. 1, 21, 34 Recent research suggests that shoulder pain not only affects function during work and leisuretime activities but also may interfere with psychological and social well-being. 30 A systematic review showed that the estimated prevalence of shoulder pain in the general population varies greatly among studies, with a lifetime prevalence from 7% to 67%. 24 In fact, shoulder or neck pain is one of the most frequent work-related complaints and a frequent reason for work absence. 26 Data from a prospective study conducted in the Netherlands showed that 30% of the workers diagnosed with a new episode of shoulder pain reported taking sick leave during the 6-month follow-up time because of the shoulder disorder.
The shoulder is one of the most complex joints of the human body. Shoulder-related disorders account for substantial medical, economic, and social costs 21, 43, 46 and comprise a wide spectrum of problems. Shoulder disorders are mostly accompanied by pain and restricted movement of the arm or shoulder that lead to difficulties in performing certain activities. 1, 21, 34 Recent research suggests that shoulder pain not only affects function during work and leisuretime activities but also may interfere with psychological and social well-being. 30 A systematic review showed that the estimated prevalence of shoulder pain in the general population varies greatly among studies, with a lifetime prevalence from 7% to 67%. 24 In fact, shoulder or neck pain is one of the most frequent work-related complaints and a frequent reason for work absence. 26 Data from a prospective study conducted in the Netherlands showed that 30% of the workers diagnosed with a new episode of shoulder pain reported taking sick leave during the 6-month follow-up time because of the shoulder disorder. 19 The impact of shoulder disorders can be assessed in different ways. Traditionally, the assessment has been performed locally by focusing on the functional aspects of the pathology and evaluating the range of motion, strength, or pain. 3 However, especially because the value of patientreported outcome (PRO) measures is becoming recognized and widely used in medical research, this approach is changing. Nowadays, research aims to determine the overall impact this problem has on daily life activities and how the psychological well-being of the patient is affected. 3 PRO instruments provide subjective information given by the patient himself or herself. PROs generally focus on the assessment of physical function, psychosocial issues, or general health-related quality of life, trying to capture the possible effect of a condition, a disease, or an intervention by incorporating the experience and perception of the patient. 4, 41 Numerous generic and disease-specific PRO measures exist. 13 Several share a similar purpose, content, and applicability, yet slight differences might exist, calling for the need to evaluate those instruments considering their strengths and weaknesses. For example, some of the PRO measures have been designed for the whole upper extremity; others, specifically for the shoulder. Some instruments are shoulder disease-specific (eg, rotator cuff disease or osteoarthritis) or population specific (eg, wheelchair users), 9, 25, 48 whereas others are independent of the underlying condition. Therefore, it is a complicated task to select the correct PRO measure for a specific purpose, considering among all those available.
PRO measurement requires reliable and valid instruments, which must be adequately selected based on the individual study purpose, setting, and available resources. Direct comparison among instruments regarding their performance characteristics, such as measurement model, metric properties, and administration issues, can facilitate this task. Efforts have been made to classify or evaluate shoulder-specific PRO measures, 2, 3, 16, 27, 29, 33, 37, 38 but so far, neither has the whole spectrum of the performance characteristics been examined nor has a direct comparison among shoulder-specific PRO measures been undertaken.
The EMPRO (Evaluating Measures of Patient Reported Outcomes) tool was developed to facilitate a standardized, comprehensive, and comparative evaluation of PRO measures. 42 It combines 3 fundamental requirements: (1) welldescribed and established quality attributes for assessment, (2) expert reviewers to conduct the assessment, and (3) scores that allow direct comparisons among outcome measures. The EMPRO tool is based on an exhaustive series of recommendations regarding the ideal attributes of PRO measures. 40 It has been shown to be valid and useful in the evaluation of generic patient-reported outcome measures, 42 as well as for specific pathologies such as heart failure 12 and localized prostate cancer. 39 The aim of this study was to perform a standardized and systematic evaluation of the available evidence on the development process, metric properties, and administration issues of multi-item shoulder-specific PRO measures that are applicable to a wide spectrum of shoulder disorders. Our results should help clinicians and researchers to select the best-performing shoulder-specific PRO measure.
Materials and methods

Identification of shoulder-specific PRO measures and their relevant information
We carried out a systematic literature review in the PubMed database (March 2011) to obtain all the available published evidence. We combined keywords using Medical Subject Headings (MeSH) terms and free-text entries: (Shoulder or Shoulder Joint or Shoulder Pain or Rotator Cuff) and (Quality of Life or Questionnaires or Disability Evaluation or Cross-Cultural Comparison) (Appendix 1, available on the journal's website at www. jshoulderelbow.org). Articles were eligible for inclusion if they contained information on the development process, the metric properties, or the administration issues of multi-item shoulderspecific PRO measures. We excluded articles about PRO measures designed for musculoskeletal conditions in general, the upper extremity as a whole, specific shoulder conditions (eg, osteoarthritis or instability), specific populations (eg, wheelchair users or athletes), and systemic diseases (eg, breast or oral cancer). We furthermore excluded research protocols, congress abstracts, secondary research articles, and articles not available in English.
In a 3-step process, titles, abstracts, and full-text articles were independently reviewed by 2 investigators (one trained in health sciences [S.S.] and the other trained in medical statistics [K.V.], both holding a Master of Public Health). A third researcher (M.F.) was appointed to mediate and resolve possible discrepancies in each of the steps. In addition, we examined the bibliographic reference lists in the articles selected for full review manually to complete the search.
EMPRO tool
The EMPRO tool was designed to measure the quality of PRO measures and is composed of 8 attributes and 39 items. 42 It assesses how well the development process of the outcome measure was designed and how it is described (conceptual and measurement model), how well the instrument performs in terms of metric properties (reliability, validity, responsiveness to change, and interpretability), and it's administrative issues (burden, alternative modes of administration, and cross-cultural and linguistic adaptations). The EMPRO tool is a valid and reliable tool that has been used successfully in the comparison of both generic and conditionspecific PRO measures. 12, 39, 42 All EMPRO attributes and items are accompanied by a short description to explain what the expert should focus on, as well as to facilitate the understanding of the intended meaning of each item in the evaluation process to guarantee standardization. Agreement with each item is measured on a 4-point Likert scale, from 4 (strongly agree) to 1 (strongly disagree). Experts can check the ''no information'' box in case of insufficient information. Five items allow a reply of ''not applicable.'' Experts are asked to provide detailed comments to justify their ratings on each item. These comments aid in the interpretation of the EMPRO scores.
Standardized and systematic EMPRO evaluation
Each shoulder-specific PRO measure was assigned to 2 different experts, who had been identified and invited because of their expertise and experience in PRO measurement (6 belonged to the EMPRO tool development working group and 16 had previously been accredited as EMPRO experts by undergoing a training course). To minimize the potential for bias, the experts were not authors and had not been involved in the development, evaluation, or adaptation process of any of the instruments evaluated.
The EMPRO evaluation process consisted of 2 consecutive rounds. In the first round, every expert evaluated the assigned shoulder-specific PRO measure independently by reviewing the provided full-text articles that were identified in the systematic literature review and then applying the EMPRO tool. 42 In the second round, each expert was provided with the rating results of the other reviewer. In case of discrepancies, they were invited to resolve them through discussion to reach a final consensus. A third reviewer was available to settle discrepancies if needed.
Calculation of EMPRO scores
The attribute-specific scores were obtained by calculating the response mean of the applicable items when at least 50% of them were rated. Items for which the option ''no information'' had been selected were assigned a score of 1 (lowest possible score). The response means were then linearly transformed to a range of 0 to 100 (worst to best). Separate subscores for reliability and burden were calculated because these attributes are divided into 2 components: ''internal consistency'' and ''reproducibility'' for reliability and ''respondent'' and ''administrative'' for burden. For reliability, the highest subscore was then chosen to represent the attribute score. In addition, we calculated an overall score that consisted of the mean of the 5 metric-related attributes: conceptual and measurement model, reliability, validity, responsiveness to change, and interpretability. The overall score was only calculated when at least 3 of these 5 attributes had a rating (0 was assigned to attributes with insufficient information). EMPRO scores were considered reasonably acceptable 12 if they reached at least 50 points (half of the maximum score). We calculated the weighted k statistics for ordinal response scales to assess the degree of agreement between experts in the EMPRO ratings. The agreement coefficient is interpreted as follows: less-than-chance agreement, 0 or less; slight agreement, 0.01 to 0.20; fair agreement, 0.21 to 0.40; moderate agreement, 0.41 to 0.60; substantial agreement, 0.61 to 0.80; and almost perfect agreement, 0.81 to 0.99. 45 Analysis was performed with SPSS statistics software, version 12 (SPSS, Chicago, IL, USA), and graphics were designed with Microsoft Excel 2003 (Microsoft, Redmond, WA, USA).
Results
We identified 2,325 articles in our systematic literature search ( Fig. 1) . After the title review, we excluded 1,726 articles because they were not topic related. Abstracts were reviewed, and a further 224 articles were excluded: 111 did not contain any PRO measure; 40 used only generic PRO measures; 33 were secondary research articles; 30 included disease-specific outcome measures other than shoulder disorder measures; 8 were lacking information regarding the development process, metric properties, or administration issues; and 2 articles were written in a language other than English. We identified 375 articles with information concerning 52 different instruments. After application of the defined exclusion criteria, 274 articles related to 41 instruments were excluded, mostly because they were only applicable to patients with a shoulder-specific condition (11 instruments) or they were not patient-reported (9) or not shoulder specific (5) . By reviewing the bibliographic lists of the identified articles, we included 11 additional articles that met the inclusion criteria. Finally, 112 articles provided information about the development process, metric properties, or administration issues of 11 shoulder-specific PRO measures at the end of the review process.
Eleven shoulder-specific PRO measures, together with information regarding their performance characteristics, were identified and evaluated with the EMPRO tool ( Table I ). The number of published articles found varied per measure from 2 to 30. The instruments were developed between 1987 and 2003 and are applicable to a variety of shoulder disorders. Of the 11 instruments, 7 are unidimensional; the others include 2 to 7 dimensions. Their content is mainly related to pain and function and is assessed by the evaluation of daily life activities. The outcome measures with a broader focus may additionally include psychosocial issues (appetite or social contacts) or satisfaction with shoulder performance. Answer options are based on dichotomous scales (yes/no answer options) or Likert, numeric, or visual analog scales. The number of items included varies from 5 to 30. They take between 3 and 10 minutes to complete, and the time framework ranges from the last 24 hours to the last month.
Agreement between pairs of experts on the first independent evaluations was moderate to substantial (weighted k coefficient 0.4) for most instruments, whereas for 3 instruments, the agreement was fair (0. 26 Table II and summarized graphically in Figure 2 . Final EMPRO scores were determined by a consensus rating between the 2 experts for every outcome measure; in most cases, the third reviewer was not needed for discrepancy resolution. The overall summary scores oscillated between 77.4 and 26.7 points. Thereby, 6 of the 11 shoulder-specific PRO measures scored above the threshold of 50 points, thus presenting acceptable overall results: the American Shoulder and Elbow Surgeons shoulder assessmentdpatient selfevaluation section (ASES-p), the Simple Shoulder Test (SST), the Oxford Shoulder Score (OSS), the FLEX-SF, the Shoulder Pain and Disability Index (SPADI), and the Dutch Shoulder Disability Questionnaire (SDQ-NL). Appendix 2 (available on the journal's website at www. jshoulderelbow.org) shows the articles used in the EMPRO evaluation.
The scores for the conceptual and measurement model ranged from 81 to 14.3 points, whereby the ASES-p (81 points) and the OSS, FLEX-SF, and SDQ-NL (66.7 points for each) reached the highest scores. Four instruments scored below 50 points, whereas for the Penn Shoulder Score (PSS), we could not find sufficient information to calculate this attribute. Eight measures were judged to be reliable, with reliability scores ranging from 83.3 points (SPADI) to 50 points (Shoulder Rating Questionnaire). The SDQ-NL and the SSRS scored low (41.6 points), and for the United Kingdom Shoulder Disability Questionnaire, we could not find sufficient information to calculate a reliability score. Validity scores in general were quite high. The SDQ-NL reached the highest rating (93.4 points), followed by the ASES-p, FLEX-SF, and SST (all 80 points). In addition, the OSS and the SPADI were shown -Not multi-item measure [1] Articles identified by hand-search (n = 11)
Articles identified and used in the EMPRO evaluation (n = 112) [11 instruments] Figure 1 Flowchart of systematic literature review. Information about the number of articles included and excluded at each step is presented. (Table II) , the SDQ-NL reached the maximum score (100 points), whereas the ASES-p, OSS, SDQ-UK, and SSRS also presented acceptable EMPRO scores (66.7-91.7 points), meaning that they present both a low respondent and administrative burden. The attribute of alternative forms of administration was only applicable for the FLEX-SF and the SPADI, which developed a computer adaptive test version 7 and a telephoneinterview version, 47 respectively. For the other evaluated shoulder-specific PRO measures, only the original selfadministered paper version exists. Finally, the attribute of cross-cultural and linguistic adaptation (3 items) was not considered in this report because our study did not aim to assess the quality of country-specific versions. Articles reporting on the metric properties of these adapted versions (eg, Arabic, 49 Italian, 31 German, 15 Portuguese, 17 and Turkish 5 ASES-p versions) were considered in our EMPRO evaluation but were not evaluated separately.
Discussion
In this study, we assessed the quality of multi-item shoulder-specific PRO measures that are designed for patients with a wide spectrum of shoulder disorders by systematically evaluating conceptual, metric, and administrative characteristics. Twenty-two experts in PRO measurement assessed the 11 identified outcome measures, and the best rated according to the EMPRO standard criteria were the ASES-p, SST, and OSS. Acceptable results were also found for 3 other questionnaires, the FLEX-SF, SPADI, and SDQ-NL. All 6 of these instruments are relatively short and easy to administer and should be serious candidate options for a wide range of purposes and settings, specially the first 3 instruments.
The ASES-p obtained the best overall score (around 80 points), followed by the SST and OSS (both around 70 points). The ASES-p was always among the top 3 outcome measures in the 5 attributes that were used for the overall score calculation, except for the responsiveness attribute, where it obtained the fourth place because of the little information available on stable group comparison. The ASES-p repeatedly scored above 70 points, except for 
interpretability (66.7 points). It uses a minimal clinically important difference for score interpretation, which was estimated to be 6.5 points. 28 The SST scored among the top 3 in reliability, responsiveness to change, and interpretability. In contrast, it scored low (52.4 points) for the attribute of conceptual and measurement model because insufficient information was found about its development process, involvement of the target population, and measurement level. An anchor-based strategy is proposed for its interpretation by linking its scores with different levels of disease severity. 14 The OSS was among the top 3 in conceptual and measurement model and in interpretability, and it also reached good results for validity and responsiveness. Its reliability was below 70 points because some aspects of methods (such as data collection or time interval for test-retest evaluation) could be either improved or better described. Because these 3 instruments are similar in content, number of items, and administration time, the choice among them could be made based on their dimensionality or answer options: the ASES-p is bidimensional and permits separate scores to be obtained for pain and function, using a visual analog scale for pain and Likert scales to assess function; the SST and OSS are unidimensional, with dichotomous and Likert response options, respectively.
The FLEX-SF, SPADI, and SDQ-NL shared an overall score around 60 points. These 3 instruments presented acceptable results for all attribute-specific scores except 1: the FLEX-SF failed on responsiveness, the SPADI on interpretability, and the SDQ-NL on reliability. Regarding the FLEX-SF, 6 its primary feature comes from its structure of 3 different testlets designed to minimize the respondent's burden. Each testletdeasy, medium, and harddconsists of 15 items that can then be flexibly administered offering each patient only adequate questions, although the initial screening question could require a higher administrative burden. In addition, a computer adaptive test version 7 has been developed and evaluated to facilitate data administration in large studies, although it requires greater resources such as hardware and software. Nevertheless, the low expert ratings on the responsiveness attribute deserve comment: Although high standardized coefficients were reported, it was not clear which methods were used in the longitudinal design to obtain them.
The SPADI 36 is a commonly used instrument but it clearly requires further research for interpretability. The SPADI's answer options initially consisted of visual analog scales but were later transformed to numerical scales with the purpose of making it suitable for telephone administration, an alternative version which was also judged to be reliable and valid. 47 The SDQ-NL requires further reliability testing. However, it could be a very good option for measuring change over time in longitudinal studies or clinical surveillance, not only because of its excellent responsiveness but also because of its low respondent burden (average time needed to complete <3 minutes and easy yes/no answer options). Our study has some limitations that deserve discussion. First, the basis of the EMPRO evaluation is the information retrieved from a systematic literature review conducted only in the PubMed database. Although PubMed is the leading database in health sciences, we may have failed to identify all the eligible shoulder-specific PRO measures or all the published articles with their specific information on the development process, metric properties, and administration issues. However, our sensitive search strategy, as well as the additional hand search of identified articles, may have minimized this problem. Second, because the EMPRO assessment is based on the published evidence, it is affected by the quantity and quality of this available information. A lack of evidence on a few items or attributes penalizes the EMPRO results because the worst possible rating is assigned in these cases. Nevertheless, to avoid a strong penalization, the score of the EMPRO attribute was not obtained if more than half of the items were missing. Most of the evaluated instruments were penalized because of missing information on the interpretability attribute, pointing out the necessity of developing interpretability strategies as a facilitator for the extension of these measures beyond the research setting. Third, the EMPRO ratings may have been biased by the individual expertise of the evaluators. However, the review by pairs, the consensus round, and the instructions on EMPRO items may have attenuated this concern. Finally, because our objective was to conduct an EMPRO evaluation of the instrument, studies conducted with country-specific versions were Figure 2 Overall ranking of instruments and their attribute-specific EMPRO scores. EMPRO scores ranged from 0 to 100 (worst to best). Instruments included the following: ASES-p; FLEX-SF; OSS; PSS; SDQ-NL; United Kingdom Shoulder Disability Questionnaire (SDQ-UK); SPADI; Shoulder Rating Questionnaire (SRQ); Shoulder Severity Index (SSI); SSRS; and SST. considered but not evaluated separately because it was not feasible. Despite the noise that these country-specific versions could have introduced in the final ratings, we think that adding them reflects the whole spectrum of currently available evidence.
To our knowledge, this is the first study that provides a standardized and reliable expert-based evaluation of the available shoulder-specific PRO measures used in patients with different disorders. The basis of our assessment is the available published information retrieved in a systematic literature review. Each outcome measure was independently reviewed by 2 experts who reached final ratings by consensus. Our findings can be of interest in clinical practice as well as in research to help in selecting the correct shoulderspecific PRO measure for a certain purpose, facilitating decision making for individual patient care, or improving patient-doctor communication by understanding how the patient feels and acts in daily life. We would like to highlight that we excluded specific shoulder condition measures (eg, osteoarthritis or instability) from our evaluation because they were beyond the scope of this article. Nevertheless, their use might be more adequate in some situations. Furthermore, we would like to add that instruments developed to be responded to by a clinician (eg, the Constant shoulder score) were not included because the EMPRO tool is specifically designed for PRO measures and contains certain items that are only applicable to this purpose.
Conclusions
The evidence presented suggests that the ASES-p, SST, and OSS are the first options for measuring function and disability in patients with shoulder disorders. These instruments have been shown to be highly reliable, valid, and responsive, with an acceptable conceptual and measurement model, interpretability, and low administrative burden. The use of the FLEX-SF, SPADI, and SDQ-NL can also be recommended because they presented acceptable properties for most of the attributes. Choosing among these instruments will mainly depend on particular study requirements. For use in longitudinal studies or clinical trials, where responsiveness to change and reproducibility are the maximum priority, the SST would be recommended. In clinical practice, for patient surveillance, the SDQ-NL might be preferred to minimize respondent and administrative burden, but further information on its reliability is needed. To discriminate among patients' or groups' evaluations at one point of time, the ASES-p or OSS could be the most reliable and valid option. Our results may facilitate the decision-making process regarding the correct instrument selection and its use and interpretation for a certain study purpose or setting. Nevertheless, more research on the metric properties of these instruments is necessary because some of the evaluations were based on a small number of articles. In addition, there is room for improvement in the overall score even for the best instruments currently available.
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